Ronny Renfurm
Chief Medical Officer at Purespring Therapeutics - The London Bioscience Innovation Centre Londo, N/A, gb
Ronny Renfurm's Colleagues at Purespring Therapeutics
Ronny Renfurm's Contact Details
HQ
N/A
N/A
Location
Netherlands
Netherlands
Company
Purespring Therapeutics
Purespring Therapeutics
Ronny Renfurm's Company Details
Purespring Therapeutics
The London Bioscience Innovation Centre Londo, N/A, gb • 20 - 49 EmployeesBioTech/Drugs
Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.
Frequently Asked Questions about Ronny Renfurm
Ronny Renfurm currently works for Purespring Therapeutics.
Ronny Renfurm's role at Purespring Therapeutics is Chief Medical Officer.
Ronny Renfurm's email address is ***@purespringtx.com. To view Ronny Renfurm's full email address, please signup to ConnectPlex.
Ronny Renfurm works in the Research industry.
Ronny Renfurm's colleagues at Purespring Therapeutics are Aikaterini Papagianni, Yaseen Mohammed, Roma Muccio, Martin Madill, Alan Ph.D, Marzena Murawska, Katy Linkens and others.
Ronny Renfurm's phone number is N/A